Dental care for a patient using bisphosphonates: Case report
DOI:
https://doi.org/10.33448/rsd-v12i7.42594Keywords:
Bisphosphonates; Osteonecrosis of the jaws; Oral surgery; Case report.Abstract
Introduction: Bisphosphonates (BPs) are currently the most relevant class of antiresorptive agents used in the treatment of bone pathologies, such as multiple myeloma, bone metastases, Paget's bone disease, osteogenesis imperfecta and osteoporosis. The mechanism of action of these drugs reduces the lifetime and function of osteoclasts, interfering with the bone remodeling process. In addition, they also promote inhibitory effects on inflammation mediators, which influence the bone repair process. Therefore, when used in association with dental surgical interventions, there is an increase in postoperative complications, since one of the steps for bone repair is remodeling, which is affected by bisphosphonates. The complications resulting from its use came to be called Osteonecrosis of the Jaws related to bisphosphonates. Objective: This paper aims to report the case of a female patient, 70 years old, with osteoporosis and systemic arterial hypertension, who uses sodium alendronate bisphosphonate (Osteoform®). The patient attended the Oral Surgery Clinic at Faculdade Paulo Picanço in need of extraction of the residual root of element 45, and underwent the surgical procedure. The procedure was performed under antibiotic coverage followed by laser therapy sessions. The patient was followed up for a period of 6 months, aiming to guarantee a good prognosis. Final considerations: Bisphosphonates (BFs) are first-choice drugs for various bone pathologies and their use is increasingly frequent. Preventive treatment plays a key role in reducing the chances of bisphosphonate-related Osteonecrosis of the Jaws (BMB). Currently, there are still no defined therapeutic dental protocols for the treatment of OMB, which emphasizes the importance of prevention as the best option in coping with this condition. Dental care prior to starting therapy with antiresorptive drugs is essential and should be an integral part of the treatment plan for patients who will use these drugs.
References
Almeida, A. C. de, Paulo, L. F. B. de, Vasconcelos, L. S., & Lima, L. B. (2021). Tratamento da osteonecrose dos maxilares associada ao uso de medicamentos - revisão de literatura. Research, Society and Development, 10(2), e4210212168. https://doi.org/10.33448/rsd-v10i2.12168
Aragão, J. M. R. de, Amorim, K. de S., Cunha, R. S. da, Groppo, F. C., & Souza, L. M. de A. (2016). Comparação do nível álgico no bloqueio do nervo alveolar inferior através de duas técnicas distintas. Revista de Odontologia Da UNESP, 45(6), 322–326. https://doi.org/10.1590/1807-2577.04216
Barasch, A., Cunha-Cruz, J., Curro, F. A., Hujoel, P., Sung, A. H., Vena, D., Voinea-Griffin, A. E., CONDOR Collaborative Group, Beadnell, S., Craig, R. G., DeRouen, T., Desaranayake, A., Gilbert, A., Gilbert, G. H., Goldberg, K., Hauley, R., Hashimoto, M., Holmes, J., Latzke, B., Leroux, B., & Yin, W. (2011). Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN. Journal of dental research, 90(4), 439–444. https://doi.org/10.1177/0022034510397196
Carneiro, L. K. De A., Fernandes, V. P., & Conceição, L. S. da. (2020) Osteonecrose associada à cirurgia odontológica decorrente do uso de bifosfonatos: revisão de literatura. FACIT Business and Technology Journal, 3(19), 72-82. https://jnt1.websiteseguro. com/index.php/JNT/article/view/727
Damasceno, J. R., Rabelo, A. H. P., & Guedes, C. do C. F. V. (2022). Osteonecrose dos Maxilares Relacionada a Medicamentos (ONMM), uma revisão de literatura acerca do conhecimento dos profissionais e orientação dada ao paciente para redução do risco. Research, Society and Development, 11(12), e31111233818. https://doi.org/10.33448/rsd-v11i12.33818
Dorigan, M. C., Matias, J. B., Tognetti, V. M., & Torres, S. C. M. (2021). A osteonecrose dos maxilares induzida por bifosfonatos: uma revisão de literatura. Research, Society and Development, 10(16), e92101623466. https://doi.org/10.33448/rsd-v10i16.23466
Fernandes, N. D. L., Lopes, G. M., Rodrigues, M. C., Carneiro, G. K. M., Carneiro, K. H. da S., Soprani Júnior, G., Oliveira, F. R. de, Padilha, I. P., Rabelo, I. B. de M., & Silva, G. C. da. (2022). Osteonecrose dos maxilares induzidas por medicamentos: como prevenir e tratar. Research, Society and Development, 11(12), e210111234568. https://doi.org/10.33448/rsd-v11i12.34568
Gridelli C. (2007). The use of bisphosphonates in elderly cancer patients. The oncologist, 12(1), 62–71. https://doi.org/10.1634/theoncologist.12-1-62
Lima, R. C., Almeida, R. F. de, & Felino, A. (2014). Profilaxia antibiótica na prevenção da infeção associada aos terceiros molares. Bioscience Journal, 30(2), 585–593. Retrieved from https://seer.ufu.br/index.php/biosciencejournal/article/view/19710
Marx, R. E., Sawatari, Y., Fortin, M., & Broumand, V. (2005). Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 63(11), 1567–1575. https://doi.org/10.1016/j.joms.2005.07.010
Meneguini, L. S., Nogueira, G. T., Tavares, L. B., Albergaria, B., Veloso, T. R. G., Alencar, C. O. de & Bianchi, P. R. (2017) Avaliação de fatores de risco para osteonecrose em pacientes usuários de Bifosfonatos no HUCAM/UFES. Braz J Periodontol, 27.
Monte, F. M. M., & Furtado, M. A. M. . (2023). Bisfosfonatos e osteonecrose maxilar: uma revisão narrativa da literatura. Research, Society and Development, 12(4), e20812441166. https://doi.org/10.33448/rsd-v12i4.41166
Mourão, C. F.; Moura, A. P.; & Ferreira Manso, J. E. (2013). Tratamento da osteonecrose dos maxilares associada aos bifosfonatos: revisão da literatura. Rev. bras. cir. Cabeça pescoço.
Pereira, A. S., Shitsuka D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica. UFSM.
Pereira, F. T., Holanda, L. A. L. de., Medeiros, N. M. de., Tavares, C. de L., Silva, E. D. O. e, & Vidal, A. K. de L. (2022). Osteonecrose mandibular e o uso de bisfosfonato em paciente oncológico: relato de caso. Research, Society and Development, 11(13), e402111335621. https://doi.org/10.33448/rsd-v11i13.35621
Ruggiero, S. L., Dodson, T. B., Aghaloo, T., Carlson, E. R., Ward, B. B., & Kademani, D. (2022). American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 80(5), 920–943. https://doi.org/10.1016/j.joms.2022.02.008
Ruggiero, S. L., Dodson, T. B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B., O'Ryan, F., & American Association of Oral and Maxillofacial Surgeons (2014). American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 72(10), 1938–1956. https://doi.org/10.1016/j.joms.2014.04.031
Silva, P. G B., Ferreira Junior, A. E. C., de Oliveira, C. C., Brizeno, L. A. C., Wong, D. V. T., Lima Júnior, R. C. P., Sousa, F. B., Mota, M. R. L., & Alves, A. P. N. N. (2017). Chronic treatment with zoledronic acid increases inflammatory markers in periodontium of rats. Journal of oral pathology & medicine: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 46(10), 1046–1053. https://doi.org/10.1111/jop.12640
Vasconcelos, R. A. O., Damasceno, C. R., & Silva, J. L. B. da. (2023). Osteonecrose dos maxilares associada ao uso de bifosfonatos: uma revisão de literatura. Revista Fluminense de Odontologia, 2(61), 118–131. https://periodicos.uff.br/ijosd/article/view/56802
Weber, J. B., Camilotti, R. S., & Ponte, M. E. (2016). Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): a systematic review. Lasers in medical science, 31(6), 1261–1272. https://doi.org/10.1007/s10103-016-1929-4
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Giovanna Déa Mitre Wenzel; Diego Feijão Abreu; Ricardo Anderson de Oliveira Vasconcelos; Arlindo Wenzel Netto; Thiago Fonteles de Sousa; Graziele de Lima Klen; Cícero Alexandre Oliveira Sá
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.